1. MARKETS
  2. SECTOR : BANKING & FINANCE
  3. INDUSTRY : FINANCIAL CONGLOMERATES
  4. DEEP MEDICINE ACQUISITION CORP - ORDINARY SHARES - CLASS A
Deep Medicine Acquisition Corp - Ordinary Shares - Class A
XNAS: DMAQ
Download real time
2.56-0.08(-3.03%)
54.61% Fall from 52W High
110.1K
XNAS Volume

XNAS 05 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Deep Medicine Acq Corp (Class A) quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Deep Medicine Acq Corp (Class A) quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
  • NEUTRAL

    Quarterly Revenue Deep Medicine Acq Corp (Class A) Sep-2023 Quarterly Revenue is $0 Million which is growth of 0% YoY.

  • NEGATIVE

    Quarterly Net Profit Deep Medicine Acq Corp (Class A) Sep-2023 Quarterly Net Profit is $-0 Million which is growth of -63.3% YoY.

Deep Medicine Acquisition Corp - Ordinary Shares - Class A, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphSep '23Jun '23Mar '23Dec '22Sep '22Jun '22Mar '22Dec '21Sep '21Jun '21Mar '21Dec '20
Operating Rev.
Cost Of Rev.
00000000000.1
Gross Profit
-0-0-0-0-0-0-0-0-0-0-0.1
⌄
0.30.30.60.40.70.30.20.10.10
Operating Profit
⌄
0.1-----------
Profit Before Tax
-0.3-0.3-0.70.7-0.2-0.2-0.2-0.1-0.1-0-0.1
Tax
-00.1-
⌄
-0.3-0.3-0.70.6-0.2-0.2-0.2-0.1-0.1-0-0.1
Diluted NI Avail to Com Stockholders Ann.
-0.3-0.3-0.70.6-0.2-0.2-0.2-0.1-0.1-0-0.1
Basic EPS
-0.1-0.1-0.10-0-0-0-0
Diluted EPS After ExtraOrdinary
-0.1-0.1-0.1-0-0-0-0-0
Number Of Shares End
4.44.64.64.616.416.416.416.416.416.4--
Net Income Continuing Discontinued Operations
-0.3-0.3-0.70.6-0.2-0.2-0.2-0.1-0.1-0-0.1
Normalized Income
-0.3-0.4-0.8-0.4-0.7-0.3-0.2-0.1-0.1-0-0.1
Interest Income
0.1-----------
Interest
------------
Net Interest Income
0.1-----------
EBIT
-0.4-0.4-0.8-0.4-0.7-0.3-0.2-0.1-0.1-0-0.1
EBITDA
-0.4-0.4-0.8-0.4-0.7-0.3-0.2-0.1-0.1-0-0.1
Reconciled Cost Of Rev.
00000000000.1
Reconciled Depr.
------------
Profit From Continuing Operations
-0.3-0.3-0.70.6-0.2-0.2-0.2-0.1-0.1-0-0.1-
Normalized EBITDA
-0.4-0.5-0.9-1.5-1.3-0.4-0.2-0.1-0.1-0-0.1
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Deep Medicine Acq Corp (Class A) competitor comparison and performance snapshot within industry

Deep Medicine Acq Corp (Class A) annual results: revenue, profit, P&L, and margins as of Mar 2023 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEUTRAL

    Annual Revenue Deep Medicine Acq Corp (Class A) Annual Revenue is $0 Million which is growth of 0% YoY.

  • POSITIVE

    Annual Net Profit Deep Medicine Acq Corp (Class A) Annual Net Profit is $-0 Million which is growth of 3.3% YoY.

Deep Medicine Acquisition Corp - Ordinary Shares - Class A, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphTTMMar '23Mar '22Mar '21
⌄
 -
Cost Of Rev. Ann.
0.10.10.1-
Gross Profit Ann.
-0.1-0.1-0.1-
Operating Exp. Ann.
1.62.20.4
Operating Profit Ann.
 -2.2-0.4
⌄
 ---
Other Exp. Ann.
 1.8-
PBT Ann.
-0.6-0.3-0.4-
Tax Ann.
0.10.1-
⌄
-0.6-0.4-0.4-
Diluted NI Avail to Com Stockholders Ann.
-0.6-0.4-0.4-
EPS Ann.
 -0-0.1-
Diluted EPS Ann.
 -0-0.1-
Number Of Shares End
 4.616.4-
Total Exp. Ann.
 2.20.4-
Net Income Continuing Discontinued Operations Ann.
-0.6-0.4-0.4-
Normalized Income Ann.
-1.8-1.8-0.4-
Interest Income Ann.
 ---
Interest Ann.
 ---
EBITDA Ann.
-1.9-2.2-0.4-
Reconciled Cost Of Rev. Ann.
0.10.10.1-
Reconciled Depr. Ann.
 ---
Profit From Continuing Operations Ann.
-0.6-0.4-0.4-
Normalized EBITDA Ann.
-3.2-4-0.4-
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Operating Exp. Ann.
1Y CHG
450%

Deep Medicine Acq Corp (Class A) balance sheet as of Mar 2023: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Total Shareholders Fund Deep Medicine Acq Corp (Class A) Mar-2023 Total Shareholders Fund is $3 Million which is growth of -97.9% YoY.

  • NEGATIVE

    Total Assets Deep Medicine Acq Corp (Class A) Mar-2023 Total Assets is $10 Million which is growth of -92.4% YoY.

Deep Medicine Acquisition Corp - Ordinary Shares - Class A, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphMar '23Mar '22Mar '21
⌄
9.81290.5
⌄
7.250.6
⌄
2.6124-0
Total Capitalization Ann.
2.61240.5
Tangible Assets Ann.
2.6124-0
Working Capital Ann.
7128.40.5
Invested Capital Ann.
4.4124.50.5
Tangible Book Value Ann.
2.6124-0
Borrowings Ann.
1.90.50.5
Net Debt Ann.
1.3--
Share Issued Ann.
4.616.416.4
Number Of Shares End
4.616.4-
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
-92.4%
2Y CAGR
342.7%
Total Current Liabilities Ann.
1Y CHG
460%
Total ShareHolders Funds Ann.
1Y CHG
-97.9%

Deep Medicine Acq Corp (Class A) ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2023 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEUTRAL

    Book Value Per Share Deep Medicine Acq Corp (Class A) Book Value Per Share is $0 which is growth of 0% YoY.

  • POSITIVE

    ROE Deep Medicine Acq Corp (Class A) ROE is -1% which is growth of 0.0% YoY.

Deep Medicine Acquisition Corp - Ordinary Shares - Class A, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphMar '23Mar '22Mar '21
RoA Ann. %
-0.58%-0.64%-
ROE Ann. %
-0.63%-0.67%-
ROIC %
---
OPM Ann. %
---
Inventory Turnover Ratio Ann.
---
Asset Turnover Ann. %
---
Working Capital Turnover Ann.
-
Quick Ratio Ann.
0.21.612.2
Current Ratio Ann.
3.5240.313.1
Interest Coverage Ratio Ann.
---
LT Debt To Equity Ann.
---
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Current Ratio Ann.
1Y CHG
-98.5%
2Y CAGR
-48.3%

Deep Medicine Acq Corp (Class A) cash flow: net, operating, investing, and financing flows as of Mar 2023 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Cash From Operating Activity Deep Medicine Acq Corp (Class A) Cash From Operating Activity is $-1 Million which is growth of -48.5% YoY.

  • NEGATIVE

    Net Cash Flow Deep Medicine Acq Corp (Class A) Net Cash Flow is $-0 Million which is growth of -174.7% YoY.

Deep Medicine Acquisition Corp - Ordinary Shares - Class A, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphMar '23Mar '22Mar '21
⌄
-1-0.7-
⌄
120.4-127.8-
⌄
-119.7128.8-
Cash Plus Cash Eqv. End Of Year Ann.
0.60.9-
Net Increase In Cash Plus Cash Eqv.s Ann.
-0.30.4-
Cash Plus Cash Eqv. Begin Of Year Ann.
0.90.5-
Income Tax Paid Supplemental Data Ann.
-
Interest Paid Supplemental Data Ann.
-
Capex Ann.
---
Issuance Of Capital Stock Ann.
129.2-
Issuance Of Debt Ann.
1.4-
Repayment Of Debt Ann.
---
Repurchase Of Capital Stock Ann.
-121--
Free Cash Flow Ann.
-1-0.7-
*All financials are in USD Million and price data in USD
Add metric to table
Search...
×